Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...